Genitourinary Therapeutics growing with 1.2% CAGR during the forecast period, 2021-2025
The continuous increase in the prevalence of genitourinary disorders across the globe stimulates the market growth significantly.
View More Information @ https://bit.ly/2PRmXsK
In addition, rising research and development activities coupled with a vast array of pipeline drugs with a high probability of regulatory approval is anticipated to be a high impact growth rendering driver for this industry. However, patient expiry and the influx of generic therapeutics pull back the industry growth to some extent.